Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;9(4):783-795.
doi: 10.1007/s40123-020-00298-y. Epub 2020 Sep 11.

Slowing the Progression of Myopia in Children with the MiSight Contact Lens: A Narrative Review of the Evidence

Affiliations
Review

Slowing the Progression of Myopia in Children with the MiSight Contact Lens: A Narrative Review of the Evidence

Alicia Ruiz-Pomeda et al. Ophthalmol Ther. 2020 Dec.

Abstract

Myopia has become a major public health problem in the world due to the increase in its prevalence in the past few decades and due to sight-threatening pathologies associated with high myopia such as cataracts, glaucoma and especially myopic maculopathy. This article is a narrative review of the evidence that currently exists on a contact lenses (CLs) specifically designed to correct myopia and to slow its progression. To contextualise the topic we discuss the different classifications and definitions that have been used for myopia, the current burden of being myopic, and current treatment options to prevent and control its progression. There is evidence that exposure to sunlight reduces the risk of myopia onset and pharmacological treatment with atropine has been shown to be the most effective therapy for controlling its progression, followed by optical interventions such as CL fitting (orthokeratology or CLs specific for myopia control) designed to decrease retinal peripheral hyperopic defocus that seems to be the theory that suggests that axial elongation is driven by this defocus and explains why the eye continues to grow abnormally after emmetropisation and generates myopia. We will especially focus on MiSight CLs. MiSight is a daily replacement soft contact lens that has been clinically proven and approved by the US Food and Drug Administration (FDA) to control the progression of myopia in children. We analyse the optical design of MiSight CLs, as well as the results of the different efficacy and safety studies that led to the approval of the lens by the FDA. We also expose current knowledge gaps, limitations and future directions.

Keywords: MiSight contact lens; Myopia control; Soft contact lens for myopia control.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Efficacy of soft contact lenses for myopia control (own figure based on data of published articles)
Fig. 2
Fig. 2
Power profile of the MiSight CLs. (Ruiz-Alcocer J. Analysis of the power profile of a new soft contact lens for myopia progression. J Optom 2016;10(4):266–268. https://doi.org/10.1016/j.optom.2016.08.003. Reproduced with permission)

References

    1. Flitcroft DI, He M, Jonas JB, et al. IMI—defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies. Invest Ophthalmol Vis Sci. 2019;60(3):M20–30. - PMC - PubMed
    1. Spillmann L. Stopping the rise of myopia in Asia. Graefe’s Arch Clin Exp Ophthalmol. 2020;258:943–59. - PubMed
    1. Wolffsohn JS, Flitcroft DI, Gifford KL, et al. IMI—myopia control reports overview and introduction. Invest Ophthalmol Vis Sci. 2019;60(3):M1–M19. - PMC - PubMed
    1. Wong YL, Sabanayagam C, Ding Y, et al. Prevalence, risk factors, and impact of myopic macular degeneration on visual impairment and functioning among adults in Singapore. Invest Ophthalmol Vis Sci. 2018;59(11):4603–4613. - PubMed
    1. Wong TY, Ferreira A, Hughes R, Carter G, Mitchell P. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol. 2014;157(1):9–25.e12. - PubMed